Pacific Edge says US medical and legal tides have turned in its favour

Pacific Edge says US medical and legal tides have turned in its favour
Pacific Edge chief executive Peter Meintjes. (Image: Pacific Edge)
Greg Hurrell
Pacific Edge is confident its newly announced $20 million capital raise, combined with new research results and professional validation, will keep it in the bladder cancer testing game.Chief executive Peter Meintjes says a clinical endorsement from the American Urological Association (AUA) should give it the medical and legal clout to regain Medicare coverage for its bladder cancer tests in the US.The dual NZX and ASX-listed medical technology company reported a net loss of $29.9m in the 12 months to March 31, 2025, compared with $29.5m in the...

More Markets

The pros and cons of Sky’s big deal
Markets

Eden Bradfield: The pros and cons of Sky’s big deal

You'd best hope streaming and advertising revenue make up for the $1 purchase.

Infratil and Ebos help drive NZ stocks higher
Markets Market Close

Infratil and Ebos help drive NZ stocks higher

Infrastructure investor helped the sharemarket end the week on a positive note.

Tom Raynel 25 Jul 2025
Bathurst fails to strike-out Talley's claims
Markets

Bathurst fails to strike-out Talley's claims

Talley's is alleging Companies Act breaches by its coal JV partner.

Pattrick Smellie 25 Jul 2025
New CFO for KMD Brands
Markets

New CFO for KMD Brands

Carla Webb-Sear has been appointed group chief financial officer for KMD Brands.She will join the group executive team on Aug 4 and report to Brent Scrimshaw, group chief executive and managing director.She joins KMD Brands from Qantas, where she was chief financial and strategy...

Staff reporters 25 Jul 2025